English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.
Tag: Dcis
Breast Duct Treatment For Early Breast Cancer Eliminates All Signs Of Disease In Laboratory Experiments
Delivering a targeted immunotoxin into breast ducts via openings in the nipple wiped out all visible and invisible precancerous lesions in laboratory studies, led by researchers at the Johns Hopkins Kimmel Cancer Center, of very early stage breast cancers
Genetic study offers new insights into DCIS biology, progression
A new genetic study discovered that not all breast cancers that develop after DCIS arise from the original DCIS lesion. Roughly 1 in 5 are new cancers, genetically unrelated to the original DCIS.
Surgical Technique May Reduce Positive Margin Rate in Breast Cancer Patients with DCIS
According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one of every four new breast cancer cases in the United States. If left untreated, DCIS has the potential to evolve into invasive cancer, so many patients choose to have breast-conserving surgery or mastectomy after a diagnosis.
Scientists Train Computers to Recognize Which Early Stage Breast Cancers Will Spread
A new, machine-learning based approach could help doctors to separate aggressive stage 0 breast cancer from non-aggressive forms, sparing some women unnecessary mastectomies.
From breast cupcakes to breast surgery
Angela used her experience with breast cancer treatment at Beaumont to help her family, friends and surgeons see the benefits of infusing treatment with humor.
Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective
Rutgers Cancer Institute of New Jersey investigators evaluated all treatment strategies for both standard-risk and good-risk ductal carcinoma in-situ and found the most commonly recommended combination treatment for DCIS represents low-value care, while radiation therapy alone was cost-effective.